A small-angle neutron scattering study of the physical mechanism that drives the action of a viral fusion peptide☆
Graphical abstract
Introduction
The gp41 glycoprotein from the surface of the HIV-1 virus interacts directly with the cell membrane to effect fusion of the virus with the target cell (Freed and Martin, 1995). It contains a 23-residue long sequence at its N-terminus that anchors the virus to the cell (Freed and Martin, 1995). The N-terminal sequence is referred to as the fusion peptide (FP) and has the sequence AVGIGALFLGFLGAAGSTMGARS. The FP is rich in hydrophobic amino acids, supporting the idea that it interacts directly with the lipid bilayer. Mutant forms of HIV-1 with a less hydrophobic FP are less able to fuse with a target cell membrane (Felser et al., 1989; Freed et al., 1990; Bergeron et al., 1992; Freed et al., 1992), further supporting the idea that the FP interacts with the cell membrane.
Studies of the mechanism of HIV-1 FP-driven fusion focused on studies of synthetic peptides having the wild-type sequence, as well as point mutations, interacting with model lipid bilayer membranes (Rafalski et al., 1990; Slepushkin et al., 1990; Nieva et al., 1994; Martin et al., 1996; Pereira et al., 1997; Curtain et al., 1999; Mobley et al., 1999; Saez-Cirion and Nieva, 2002; Castano and Desbat, 2005). Neutral phospholipids and lower peptide concentrations display less vesicle fusion and correspond to the peptide being bound to the membranes in an α-helical conformation (Rafalski et al., 1990; Nieva et al., 1994; Martin et al., 1996; Pereira et al., 1997; Heller and Rai, 2017; Heller and Zolnierczuk, 2019). A β-sheet conformation, which is deemed responsible for FP-driven vesicle fusion, is found at higher peptide concentrations and when charged lipids are present (Rafalski et al., 1990; Nieva et al., 1994; Martin et al., 1996; Mobley et al., 1999; Heller and Rai, 2017; Heller and Zolnierczuk, 2019). The presence of divalent cations can also promote this fusogenic FP conformation (Nieva et al., 1994; Pereira et al., 1997; Saez-Cirion and Nieva, 2002). The Ebola FP (Agopian and Castano, 2014) and the FP from Paramyxovirus PIV5 (Yao and Hong, 2013) are two other examples of viral FPs that act similarly, which suggests that a common mechanism drives vesicle fusion.
To better understand the mechanisms that drive the helix-to-sheet transition and fusion, a mutant form of the gp41 FP was developed to be less fusogenic than the wild-type FP. The peptide, referred to as gp41rk, has the sequence RKGIGALFLGFLGAAGSTMKR. This peptide displays a concentration-dependent helix-to-sheet conformational transition in vesicles composed of mixtures of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) with either 1,2-dimyristoyl-sn-glycero-3-phospho-L-serine (DMPS) or 1,2-dimyristoyl-sn-glycero-3-phospho(1’-rac-glycerol) DMPG, but it does not strongly promote vesicle fusion (Heller and Rai, 2017; Heller and Zolnierczuk, 2019). When associated with DMPC:DMPS vesicles, the peptide remains in the α-helical conformation when 1/1000 ≤ P/L ≤ 1/200, but adopts a β-sheet conformation at P/L = 1/50 (Heller and Rai, 2017). The α-helical state of the peptide did not strongly perturb the structure of the bilayer (Heller and Rai, 2017), due in part to the low peptide concentrations. In contrast, the β-sheet conformation thickens the bilayer, on average, which was attributed to regions of the vesicle having more ordered chains (Heller and Rai, 2017). A later study using circular dichroism (CD) spectroscopy in 7:3 M mixtures of DMPC:DMPG revealed that the gp41rk helix-to-sheet transition in this lipid mixture occurs between P/L = 1/150 and P/L = 1/100 (Heller and Zolnierczuk, 2019). Neutron scattering measurements revealed that the β-sheet conformation of gp41rk causes the bilayer to stiffen, while the α-helical conformation did not alter the mechanical properties of the bilayer (Heller and Zolnierczuk, 2019). While these studies provided important insights into how the helix-to-sheet transition alters the bilayer, the relationship between the FP conformational transition and changes to the bilayer structure could not be correlated with vesicle fusion since it was not observed in these lipid mixtures at the peptide concentrations studied.
Here, small-angle neutron scattering (SANS) was used to develop a better understanding of the physical mechanism that drives FP-induced vesicle fusion. The gp41rk peptide was studied associating with vesicles composed of a 7:3 mixture of deuterium labeled 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS) at 0, 20 and 30 mol% cholesterol (Chol) is present. Chol is known to impact the conformation and fusogenicity of the gp41 FP (Lai et al., 2012; Lai and Freed, 2014; Yang et al., 2001a; Yang et al., 2001b; Yang and Weliky, 2003; Wasniewski et al., 2004; Sackett and Shai, 2005; Buzón and Cladera, 2006; Qiang et al., 2007; Bodner et al., 2008; Qiang et al., 2008; Qiang and Weliky, 2009; Sackett et al., 2010; Schmick and Weliky, 2010; Sackett et al., 2014; Jia et al., 2015). Circular dichroism confirmed that gp41rk adopts an α-helical or β-sheet conformation in a concentration and Chol-dependent manner. Vesicle fusion was inferred to have taken place from the SANS data collected at the highest peptide concentration studied in the vesicles containing 30 mol% Chol. Analysis of the remaining SANS data demonstrated that gp41rk has little impact on the structure of the bilayer when no Chol is present. However, at 30 mol% Chol, the peptide alters the structure of the bilayer significantly, suggesting that the underlying mechanism that drives vesicle fusion by the peptide is the free energy cost of deforming the structure of the bilayer.
Section snippets
Materials
The gp41rk peptide was synthesized in the amidated form by GenScript (Piscataway, NJ, USA) and was provided at a purity of 91.2 %. The peptide was used without further purification. Chloroform from Amresco, LLC (Solon, OH, USA), 2,2,2-trifluoroethanol from Fisher Scientific (Pittsburg, PA, USA) and D2O (99.8 % deuterium content) from Cambridge Isotope Laboratories, Inc. (Tewksbury, MA, USA) were also used without further purification. A 10.5 mg/mL stock solution of gp41rk dissolved in TFE was
Results
The CD spectra for gp41rk in the various lipid mixtures are shown in Figs. 1 and S1 and confirm that gp41rk displays a helix-to-sheet conformational transition as a function of peptide concentration and Chol content. Without Chol in the membrane, the peptide adopts a conformation that is a mixture of α-helix and random coil (Brahms and Brahms, 1980). Based on the relative amplitudes of the three bands and the position of the zero-crossing, incorporating 20 mol % Chol reduces the random coil
Discussion
The CD results presented here confirm that the gp41rk peptide undergoes a helix-to-sheet conformational transition in a concentration- and Chol-dependent manner in the lipid mixtures studied and fusion takes place at high enough peptide concentrations, even though the charged residues at each end of the sequence are anticipated to reduce its fusogenicity (Felser et al., 1989; Freed et al., 1990; Bergeron et al., 1992; Freed et al., 1992). The results are consistent with previously published
Conclusions
The mechanism that drives the membrane fusion by gp41rk, a peptide derived from the gp41 FP of HIV-1 (Freed and Martin, 1995), were investigated in POPC:POPS:Chol membranes having up to 30 mol% Chol. The conformation of gp41rk contained increasing amounts of β-sheet in 30 mol% Chol with increasing peptide concentration. Fusion was also observed in a concentration-dependent manner at 30 mol% Chol, but not at lower Chol content. The SANS results in the 30 mol% Chol vesicles obtained at P/L =
Declaration of Competing Interest
The authors report no declarations of interest.
Acknowledgements
The author would like to thank C. Gao for assistance with the EQ-SANS instrument and H. M. O’Neill for access to the CD instrument. This research used resources at the Spallation Neutron Source, a DOE Office of Science User Facility operated by the Oak Ridge National Laboratory.
References (63)
- et al.
Structure and orientation study of Ebola fusion peptide inserted in lipid membrane models
Biochim. Biophys. Acta-Biomembr.
(2014) - et al.
Mantid-Data analysis and visualization package for neutron scattering and mu SR experiments
Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.
(2014) - et al.
Determination of protein secondary structure in solution by vacuum ultraviolet circular-dichroism
J. Mol. Biol.
(1980) - et al.
Structure and orientation study of fusion peptide FP23 of gp41 from HIV-1 alone or inserted into various lipid membrane models (mono-, bi- and multibi-layers) by FT-IR spectroscopies and Brewster angle microscopy
Biochim. Biophys. Acta-Biomembr.
(2005) - et al.
Understanding inelastically scattered neutrons from water on a time-of-flight small-angle neutron scattering (SANS) instrument
Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.
(2014) - et al.
A syncytia assay for human immunodeficiency virus type-I (Hiv-I) envelope protein and its use in studying Hiv-I mutations
Virology
(1989) - et al.
The role of human-immunodeficiency-virus type-1 envelope glycoproteins in virus infection
J. Biol. Chem.
(1995) - et al.
H-2 nuclear magnetic resonance spectroscopy supports larger amplitude fast motion and interference with lipid chain ordering for membrane that contains beta sheet human immunodeficiency virus gp41 fusion peptide or helical hairpin influenza virus hemagglutinin fusion peptide at fusogenic pH
Biochim. Biophys. Acta-Biomembr.
(2020) - et al.
The amino-terminal peptide of HIV-1 glycoprotein-41 interacts with human erythrocyte membranes - peptide conformation, orientation and aggregation
Biochim. Biophys. Acta
(1992) - et al.
Changes in lipid bilayer structure caused by the helix-to-sheet transition of an HIV-1 gp41 fusion peptide derivative
Chem. Phys. Lipids
(2017)
The helix-to-sheet transition of an HIV-1 fusion peptide derivative changes the mechanical properties of lipid bilayer membranes
Biochim. Biophys. Acta (BBA) – Biomembr.
The condensing effect of cholesterol in lipid bilayers
Biophys. J.
Membrane fusion
Cell
REDOR solid-state NMR as a probe of the membrane locations of membrane-associated peptides and proteins
J. Magn. Reson.
HIV gp41 fusion peptide increases membrane ordering in a cholesterol-dependent fashion
Biophys. J.
Fusion activity of HIV gp41 fusion domain is related to its secondary structure and depth of membrane insertion in a cholesterol-dependent fashion
J. Mol. Biol.
Membrane-mediated peptide conformation change from alpha-monomers to beta-aggregates
Biophys. J.
How type II diabetes-related islet amyloid polypeptide damages lipid bilayers
Biophys. J.
Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs
Biochim. Biophys. Acta-Biomembr.
Combined influence of cholesterol and synthetic amphiphillic peptides upon bilayer thickness in model membranes
Biophys. J.
Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects
Biophys. J.
The interaction of Melittin with dimyristoyl phosphatidylcholine-dimyristoyl phosphatidylserine lipid bilayer membranes
Biochim. Biophys. Acta (BBA) – Biomembr.
The HIV fusion peptide adopts intermolecular parallel beta-sheet structure in membranes when stabilized by the adjacent N-terminal heptad repeat: a C-13 FTIR study
J. Mol. Biol.
Comparative analysis of membrane-associated fusion peptide secondary structure and lipid mixing function of HIV gp41 constructs that model the early pre-hairpin intermediate and final hairpin conformations
J. Mol. Biol.
Solid-state NMR spectroscopy of the HIV gp41 membrane fusion protein supports intermolecular antiparallel 13 sheet fusion peptide structure in the final six-helix bundle state
J. Mol. Biol.
Conformational transitions of membrane-bound HIV-1 fusion peptide
Biochim. Biophys. Acta-Biomembr.
Interaction of human-immunodeficiency-virus (Hiv-1) fusion peptides with artificial lipid-membranes
Biochem. Biophys. Res. Commun.
Kinetic process of beta-amyloid formation via membrane binding
Biophys. J.
HIV-1 fusion peptide decreases bending energy and promotes curved fusion intermediates
Biophys. J.
HIV fusion peptide penetrates, disorders, and softens T-cell membrane mimics
J. Mol. Biol.
Solid-state nuclear magnetic resonance studies of HIV and influenza fusion peptide orientations in membrane bilayers using stacked glass plate samples
Chem. Phys. Lipids
Cited by (0)
- ☆
Notice: This manuscript has been authored by UT-Battelle, LLC, under contract DE-AC05-00OR22725 with the US Department of Energy (DOE). The US government retains and the publisher, by accepting the article for publication, acknowledges that the US government retains a nonexclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this manuscript, or allow others to do so, for US government purposes. DOE will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).